Taiyen Biotech Co Ltd (1737) — Financial Flexibility Index
Taiyen Biotech Co Ltd (1737) has a Financial Flexibility Index of 0.20x as of December 2025. Free cash flow of NT$295.80 Million (operating CF NT$194.08 Million minus capex NT$101.72 Million) represents 0% of total liabilities (NT$1.45 Billion). Also explore 1737 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Taiyen Biotech Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Taiyen Biotech Co Ltd across 23 annual periods. Check 1737 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Taiyen Biotech Co Ltd. For the full company profile including market capitalisation, see market value of Taiyen Biotech Co Ltd.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | NT$773.93 Million | NT$473.77 Million | NT$1.45 Billion | ▼ -5.4% |
| 2024 | 0.56x | NT$967.73 Million | NT$660.12 Million | NT$1.71 Billion | ▲ +25.1% |
| 2023 | 0.45x | NT$799.67 Million | NT$454.54 Million | NT$1.77 Billion | ▼ -15.4% |
| 2022 | 0.53x | NT$827.29 Million | NT$580.69 Million | NT$1.55 Billion | ▲ +5.3% |
| 2021 | 0.51x | NT$990.89 Million | NT$600.08 Million | NT$1.95 Billion | ▲ +19.7% |
| 2020 | 0.42x | NT$607.25 Million | NT$339.36 Million | NT$1.43 Billion | ▼ -0.2% |
| 2019 | 0.42x | NT$615.06 Million | NT$330.81 Million | NT$1.45 Billion | ▼ -33.6% |
| 2018 | 0.64x | NT$748.32 Million | NT$449.83 Million | NT$1.17 Billion | ▼ -19.6% |
| 2017 | 0.80x | NT$977.55 Million | NT$607.87 Million | NT$1.23 Billion | ▲ +12.0% |
| 2016 | 0.71x | NT$758.36 Million | NT$568.06 Million | NT$1.07 Billion | ▲ +43.5% |
| 2015 | 0.50x | NT$490.50 Million | NT$383.93 Million | NT$990.08 Million | ▼ -13.0% |
| 2014 | 0.57x | NT$519.87 Million | NT$371.06 Million | NT$913.15 Million | ▼ -16.2% |
| 2013 | 0.68x | NT$296.74 Million | NT$203.21 Million | NT$436.66 Million | ▼ -11.8% |
| 2012 | 0.77x | NT$263.86 Million | NT$154.46 Million | NT$342.49 Million | ▼ -14.9% |
| 2011 | 0.91x | NT$322.94 Million | NT$246.09 Million | NT$356.53 Million | ▼ -21.6% |
| 2010 | 1.16x | NT$426.96 Million | NT$300.89 Million | NT$369.36 Million | ▼ -19.5% |
| 2009 | 1.44x | NT$472.69 Million | NT$358.02 Million | NT$329.10 Million | ▼ -27.8% |
| 2008 | 1.99x | NT$609.60 Million | NT$417.51 Million | NT$306.42 Million | ▲ +82.0% |
| 2007 | 1.09x | NT$402.19 Million | NT$322.49 Million | NT$367.92 Million | ▼ -11.1% |
| 2006 | 1.23x | NT$611.33 Million | NT$462.88 Million | NT$497.10 Million | ▲ +61.5% |
| 2005 | 0.76x | NT$705.10 Million | NT$575.91 Million | NT$925.79 Million | ▼ -49.9% |
| 2004 | 1.52x | NT$3.03 Billion | NT$2.84 Billion | NT$1.99 Billion | ▲ +80.1% |
| 2003 | 0.84x | NT$3.51 Billion | NT$3.42 Billion | NT$4.16 Billion | — |